COMPARISON OF ATRIAL FIBRILLATION ABLATION BLEEDING AND THROMBOTIC COMPLICATIONS WITH DABIGATRAN, RIVAROXABAN AND WARFARIN

被引：7
|
作者：
Bernard, Michael [1 ]
Brabham, William [1 ]
Netzler, Peter [1 ]
Rowley, Christopher [1 ]
Gold, Michael [1 ]
Leman, Robert [1 ]
Sturdivant, John [1 ]
Wharton, J. Marcus [1 ]
Cuoco, Frank [1 ]
机构：
[1] Med Univ S Carolina, Charleston, SC 29425 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2013年 / 61卷 / 10期
关键词：
D O I：
10.1016/S0735-1097(13)60276-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E276 / E276
页数：1
相关论文
共 50 条
  • [31] Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
    Yao, Xiaoxi
    Abraham, Neena S.
    Sangaralingham, Lindsey R.
    Bellolio, M. Fernanda
    McBane, Robert D.
    Shah, Nilay D.
    Noseworthy, Peter A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (06):
  • [32] A Comparison of Bleeding Events Among Patients on Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism
    Schaefer, Jordan K.
    Errickson, Josh
    Kong, Xiaowen
    Ali, Mona A.
    Chipalkatti, Naina
    Haymart, Brian
    Kaatz, Scott
    Krol, Gregory D.
    Sood, Suman L.
    Froehlich, James
    Barnes, Geoffrey D.
    BLOOD, 2023, 142
  • [33] Meta-Analysis of Efficacy and Safety of Rivaroxaban Compared With Warfarin or Dabigatran in Patients Undergoing Catheter Ablation for Atrial Fibrillation
    Aryal, Madan Raj
    Ukaigwe, Anene
    Pandit, Anil
    Karmacharya, Paras
    Pradhan, Rajesh
    Mainali, Naba Raj
    Pathak, Ranjan
    Jalota, Leena
    Bhandari, Yashoda
    Donato, Anthony
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (04): : 577 - 582
  • [34] Dabigatran and rivaroxaban have different risk factors for bleeding in atrial fibrillation patients
    Nishino, M.
    Okamoto, N.
    Tanaka, A.
    Mori, N.
    Yoshimura, T.
    Makino, N.
    Egami, Y.
    Shutta, R.
    Tanouchi, J.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1080 - 1080
  • [35] Original Comparison of clinical effects and costs among dabigatran etexilate, rivaroxaban and warfarin in elderly patients with atrial fibrillation
    Di, Junjun
    Wei, Yong
    Zhang, Guoqiang
    Yue, Yuguo
    Sun, Simei
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (05): : 3639 - 3646
  • [36] Atrial Fibrillation Radiofrequency Ablation on Uninterrupted Anticoagulation with Rivaroxaban Versus Warfarin
    Mendoza, Ivan
    Reina, Janet
    Baez-Escudero, Jose
    Helguera, Marcelo E.
    Pinski, Sergio L.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2014, 25 (05) : 560 - 560
  • [37] Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation
    Chan, Yi-Hsin
    Kuo, Chi-Tai
    Yeh, Yung-Hsin
    Chang, Shang-Hung
    Wu, Lung-Sheng
    Lee, Hsin-Fu
    Tu, Hui-Tzu
    See, Lai-Chu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (13) : 1389 - 1401
  • [38] Cost of Hospital Admissions in Medicare Patients With Atrial Fibrillation Taking Warfarin, Dabigatran, or Rivaroxaban
    Vaughan, Mary S.
    Jones, Michael
    Mazur, Alexander
    Cram, Peter
    Ayyagari, Padmaja
    Chrischilles, Elizabeth
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (03) : 360 - 362
  • [39] GI bleeding risk with dabigatran and rivaroxaban vs warfarin
    Reactions Weekly, 2015, 1550 (1) : 8 - 8
  • [40] Management and impact of bleeding events with dabigatran, rivaroxaban, and warfarin
    Yarabinec, Daniel M.
    Hall, Deanne L.
    Coons, James C.
    PHARMACOTHERAPY, 2013, 33 (10): : E268 - E269
12345